Delivery Order 36C26223D0011-36C26223N0178

Award Date 12/1/22
Potential Completion Date 11/30/23
Potential Value $49K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Patterson, NY 12563, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $408,630.00 delivery order contract to JRS Pharma LP for the provision of the "ProSolv EasyTab" product. The contract has a firm fixed price pricing type and does not have a set-aside designation. This recurring procurement indicates the VA-VHA's ongoing need for the ProSolv EasyTab product to support its healthcare operations. The contract has been in place since July 2018 and has been extended...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $11,724.80 firm fixed price delivery order contract to JRS Pharma LP of Patterson, New York. The one-year contract, running from December 1, 2023 through November 30, 2024, is for the purchase of PROSOLV EASYTAB SP. As the Veterans Health Administration provides healthcare services to military veterans, this contract will supply JRS Pharma's PROSOLV EASYTAB SP product to various...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 22 to JRS Pharma LP, a for-profit manufacturer of goods. The $65,286.00 firm fixed price delivery order contract is for the provision of PROSOLV EASYTAB SP, a pharmaceutical excipient product. This award is part of an ongoing indefinite delivery vehicle (IDV) contract between JRS Pharma LP and the VA VHA Veterans Integrated Service Network...
The Department of Veterans Affairs Veterans Health Administration awarded a $36,673.80 firm fixed price delivery order against GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) to Otsuka America Pharmaceutical Inc. to provide JYRARQUE for the Veterans Integrated Service Network 21. Otsuka America Pharmaceutical will deliver the medication from its location in Potomac, Maryland to support the VA-VHA's healthcare programs for veterans in the specified region. The delivery order has a period of...
The Department of Veterans Affairs Veterans Health Administration awarded a $678,720 delivery order to Emergent Devices Inc. under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. The order calls for Emergent Devices to supply pharmaceutical items to meet the clinical needs of VA's Veterans Integrated Service Network 12, located in Wayne, Pennsylvania, with performance from December 4-11, 2020. No subcontractors or set aside designations were identified. This order...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $11,317.97 delivery order to Janssen Biotech, Inc. for BALVERSA 3MG tablets. The tablets will be delivered under firm fixed price terms to a location in Frisco, Texas by August 5, 2020. The contract was awarded utilizing the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a multiple award schedule managed by the General Services Administration, which provides access to...
This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, for the provision of the medication Jynarque (tolvaptan). The $24,791.27 contract supports the VA's Veterans Health Administration (VHA) and its integrated service networks across multiple states. Otsuka holds several indefinite delivery vehicles (IDVs) with the VA, including a $396 million Federal Supply Schedule (FSS)...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a firm-fixed price delivery order to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, for the supply of JYNARQUE TABLETS 60MG/30MG. The award, with a potential value of $136,002.04, was made under Otsuka's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). This delivery order is part of Otsuka's multiple award contracts with the VA to provide...
Janssen Products LP has been awarded a $22,685.43 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract to provide SIRTURO 100MG tablets to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order has a completion date of May 26, 2023 and was awarded on March 27, 2023. It utilizes a firm fixed price contracting method and will be performed in Horsham, Pennsylvania. No...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded Otsuka America Pharmaceutical Inc. a $12,195.72 firm fixed price delivery order against the company's Pharmaceuticals and Drugs GSA Schedule contract. The delivery order is for JYNARQUE 90MG-30MG and will be performed in Pittsburgh, Pennsylvania from October 24-27, 2023. Otsuka America Pharmaceutical will provide the requested pharmaceutical products to VA-VHA under this small...
  • 36C26223D0011
    Indefinite Delivery Contract
  • 36C26223D0011-36C26223N0178
    Delivery Order

JRS Pharma LP has been awarded a $49,298.80 firm fixed price delivery order for ProSolv EasyTab under the Department of Veterans Affairs' Veterans Health Administration contract vehicle. The order is for the continued provision of ProSolv EasyTab to the Veterans Integrated Service Network 22 in Patterson, New York, with performance through November 30, 2023. ProSolv EasyTab has been consistently provided by JRS Pharma to the VA-VHA over multiple contract years, indicating customer satisfaction with the product and related services. No set-aside designation was specified.

Generated 1/3/24, 4:39 AM